Provided by Tiger Trade Technology Pte. Ltd.

Crinetics Pharmaceuticals Inc.

84.95
0.0000
Volume:- -
Turnover:697.41M
Market Cap:9.01B
PE:-16.89
High:84.95
Open:84.95
Low:84.95
Close:84.95
52wk High:85.01
52wk Low:31.00
Shares:106.10M
Float Shares:95.53M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.0290
EPS(LYR):-4.9500
ROE:-42.45%
ROA:-26.28%
PB:7.56
PE(LYR):-17.16

Loading ...

Crinetics Pharmaceuticals Q1 revenue jumps on Palsonify launch

Reuters
·
May 08

Crinetics Pharmaceuticals Q1 EPS $(1.23) Beats $(1.25) Estimate, Sales $10.306M Beat $8.512M Estimate

Benzinga Earnings
·
May 08

BRIEF-Crinetics Pharmaceuticals Q1 Net Income USD -127.845 Million

Reuters
·
May 08

Crinetics Pharmaceuticals Inc - Expects 2026 Gaap Operating Expenses $600 Mln-$650 Mln; Non-Gaap Operating Expenses $480 Mln-$520 Mln

THOMSON REUTERS
·
May 08

Crinetics Pharmaceuticals Q1 Revenue USD 10.306 Million

THOMSON REUTERS
·
May 08

Crinetics Pharmaceuticals Q1 EPS USD -1.23

THOMSON REUTERS
·
May 08

Crinetics Pharmaceuticals announces annual shareholder meeting

Reuters
·
Apr 30

Crinetics Pharmaceuticals Is Maintained at Market Outperform by Citizens

Dow Jones
·
Apr 28

Crinetics price target raised to $97 from $96 at Citizens

TIPRANKS
·
Apr 28

Crinetics’ Palsonify approved by European Commission for acromegaly

TIPRANKS
·
Apr 28

EU Commission approves Crinetics’ Palsonify for adult acromegaly treatment

Reuters
·
Apr 28

Crinetics Pharmaceuticals Announces the European Commission Approval of Palsonify® (Paltusotine) for the Treatment of Acromegaly in Adults

THOMSON REUTERS
·
Apr 28

Crinetics FY25 net loss widens to $465.3 million; revenue rises to $7.7 million

Reuters
·
Apr 16

Crinetics submits Brazil approval application for Palsonify in acromegaly

Reuters
·
Apr 16

Neutrolis Appoints Caren Deardorf as Chief Business & Strategy Officer

THOMSON REUTERS
·
Apr 16

ALX Oncology names Jeff Knight chief development and operating officer

Reuters
·
Apr 13

Crinetics Chief Development and Operating Officer Jeff Knight resigns, becomes consultant

Reuters
·
Apr 11

Crinetics to report first-quarter results after market close, host conference call

Reuters
·
Apr 09

Why Crinetics Pharmaceuticals (CRNX) Is Up 10.6% After Brazil PALSONIFY Filing Expands Global Footprint

Simply Wall St.
·
Apr 06

Crinetics submits Palsonify marketing authorization application to ANVISA

TIPRANKS
·
Mar 27